Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. - Wikidata - awgldk - TriplyDB

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

http://www.wikidata.org/entity/Q35017864

about

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?Chemokine Involvement in Fetal and Adult Wound Healing Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases Primary cutaneous anaplastic large cell lymphoma occurring in an atopic dermatitis patient: a case report with review of the literature with emphasis on their association.Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.Mast cell survival and mediator secretion in response to hypoxia Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.Association of TNFSF8 polymorphisms with peripheral neutrophil count.Mast cells as cellular sensors in inflammation and immunity Inmunohistochemical detection of mastocytes in tissue from patients with actinic prurigo Sensitization to aeroallergens in patients with respiratory allergies based on skin-prick test results.Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations Mast cells in vulnerable atherosclerotic plaques--a view to a kill.The mast cell and allergic diseases: role in pathogenesis and implications for therapy.Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation.Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome.CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes.The effect of bacterial, viral and fungal infection on mast cell reactivity in the allergic setting.IgE, mast cells, and eosinophils in atopic dermatitis.Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms.Mast Cells Respond to Cell Injury through the Recognition of IL-33.Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings Chemokine receptors in psoriasis.Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin.MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study.CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas.Interferon α2 and interferon γ induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells.A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cells.Tumor-infiltrating tryptase+ mast cells predict unfavorable clinical outcome in solid tumors.Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis.Mast cell-neural interactions contribute to pain and itch.The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice.CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.

P2860

Q21144444-533ED834-CBAD-47C0-A16A-5028C7308A3E Q26778688-76631B81-48CF-4A56-9852-3867360C2831 Q26825467-722CC9EF-2BC9-4275-AA03-0CFF88B88BE0 Q33583071-2C265A63-AC2B-4E32-85F4-D6686D9AFAAA Q33617937-F946DCAF-7B19-4B0D-895E-AE52D2BCC6CF Q33680300-F427AD8D-A236-43B4-935D-5965C8D9E786 Q34312178-E482D711-D71E-4653-81E3-923810DA784C Q34586289-DDC7AF87-D250-4EE5-BFD4-6AF449DC46D9 Q35128470-70B4E274-C9F6-4768-9849-261E84599C51 Q35460930-93525C9A-DF95-4661-8669-5F3389B36CF0 Q35927571-E8BF817E-799F-4743-9D8E-1BF42A6FA906 Q36328185-F7FABEC5-EF8F-42A9-992A-75FF236CBEF3 Q36387095-D0026F75-6AB2-4974-A648-2DE0B152A163 Q36462026-660244F0-56DC-4F15-8330-22438BB33B74 Q36924398-123E7A2D-A453-4571-9BD8-FC20ED55150E Q37010493-57896C8B-7B8F-441B-90D6-D311BC03F0A7 Q37143569-1F5B4E43-0979-43BC-BA91-566CF849117E Q37250416-54D2FE19-1F26-4F16-BCD6-CAC79939A905 Q37327528-1F572564-37F0-4B84-A8A6-757E5E64DFB4 Q37395933-0D396BFE-63C7-47D9-AC2C-9772C74B7454 Q37829600-E533B56E-1BCF-4F1F-A654-76FDB0730B13 Q37830373-5629FD7A-FBB0-460A-93BD-4652B383F9F2 Q37831903-70AFDFC5-9B96-443B-B51F-77398642CD2A Q38008374-2299B1C7-0800-4A3F-9384-51CD77242F7E Q38040121-A3AE0027-24AE-44E6-A564-BCC0C0657165 Q38144211-C7BBB133-2B42-4029-B12E-CC95F2430919 Q38218882-E7F1230E-010C-4375-87E2-BEB0C5BF720B Q39989085-B47ACC6F-98E1-49C7-AB11-6F316F1D14CF Q42506621-A1389D5B-2423-4C9D-ADCD-03C3ECD24205 Q47299162-1BFF8E63-0CE6-41A7-BA7B-EC389F3D04A9 Q47714604-51E80138-BE70-4846-84DB-7F4E205ABBDB Q48202322-F2356B4B-7948-471E-9929-FB45D14E7C27 Q48628888-B3EEC705-A4D6-4426-A58E-3420C7C7256A Q50068940-A0398426-C4F1-4804-8FBC-D8C2AE02A420 Q53234746-DC657058-EB9C-47DB-A229-124946A2E8EC Q55500218-A10D6F99-A230-48C0-86F1-E0A349377CE3

P2860

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

http://www.wikidata.org/entity/Q35017864

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@ast

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@en

type

label

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@ast

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@en

prefLabel

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@ast

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@en

P1433

Q35017864-2D4B3D0A-DF09-4617-98A1-4FF94AC8962D

P1476

Q35017864-21AFE602-96D5-43E0-BE0D-F87B9D09072E

P2093

Q35017864-3DECFE1B-6894-4F83-BB41-12D9FA590A45

Q35017864-54A6D91C-9059-4F7A-B2F3-D7923995C828

Q35017864-5F80A93C-4592-4917-84F6-E1EBACFCB209

Q35017864-61121431-2F87-4F1D-A26C-2CC92C19C6E7

Q35017864-7E61CE19-E6B9-4EF1-BCD6-6853A7881344

Q35017864-CEFC77F0-2B4A-4B91-A2FC-BA22921A9226

P2860

Q35017864-0067B95E-7209-4E92-BBA1-886BE4A306E9

Q35017864-050A04BA-D144-4EC3-BF1A-26B4CA2627D6

Q35017864-138D871A-6E40-4BAD-9222-D528657EBEC6

Q35017864-1457A497-7B55-4C64-A2B3-E9B141C9B8F4

Q35017864-14EB002F-0080-4B49-B05F-10367AC914A7

Q35017864-1D4D9CC7-031D-4BA6-AD9B-DD590034B7FE

Q35017864-1DD02D67-96DF-48F4-8D0C-A9861D056730

Q35017864-3779394C-FAE1-41B9-B46C-AEFD57170382

Q35017864-3D435EA4-8284-4E49-9407-7B5CB3677F68

Q35017864-4BF8187B-5F37-4589-9A56-09A5CC9C3E76

P304

Q35017864-3269F435-6595-4068-8041-179D51D803E2

P31

Q35017864-F9710A7E-1F72-4E64-B9AD-FC35037AAF5E

P356

Q35017864-697C3FF4-C58E-40EB-A411-10DA087F53F3

P407

Q35017864-4C2670B4-5F1B-470E-821F-98E868F8FE08

P433

Q35017864-40829239-1F86-464E-BDDE-B26077F0DAD7

P478

Q35017864-CAA02D2A-CC85-48C9-B04D-5916C499F8F5

P50

Q35017864-D9B1E50E-102D-488B-A4A4-FDADB5D0F1D7

P577

Q35017864-6CB3DC5A-8BCF-4A28-9245-7A3229464954

P698

Q35017864-1E218152-4B4C-4B52-8F71-D65417DF4587

P921

Q35017864-A0B0F93A-08AE-4C23-955B-DC767C640B29

Q35017864-F86E2D36-7600-47E2-83A3-EBCAC7FEC3D4

P932

Q35017864-FDAF50CC-C94E-4E7C-B40B-5D171D22CB38

P356

P1433

Journal of Clinical Investigation

P1476

Mast cell CD30 ligand is upreg ...... dependent chemokine secretion.

@en

P2093

Anita Naukkarinen

http://www.w3.org/2001/XMLSchema#string

Christine Möller

http://www.w3.org/2001/XMLSchema#string

Gunilla Enblad

http://www.w3.org/2001/XMLSchema#string

Ilkka T Harvima

http://www.w3.org/2001/XMLSchema#string

Marie Fischer

http://www.w3.org/2001/XMLSchema#string

Ricardo F S Carvalho

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

Points of control in inflammation

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma.

Mast cells as sentinels of innate immunity.

Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Mast cells in autoimmune disease.

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues.

P304

2748-2756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI24274

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16964309

http://www.w3.org/2001/XMLSchema#string

P921

P932

1560346

http://www.w3.org/2001/XMLSchema#string